• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄连素通过调节尿酸转运蛋白和肠道微生物群减轻高尿酸血症。

Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota.

作者信息

Shan Baixi, Wu Mingyu, Chen Ting, Tang Weiwei, Li Ping, Chen Jun

机构信息

State Key Laboratory of Natural Medicines, China Pharmaceutical University Nanjing 210009, P. R. China.

Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 210009, P. R. China.

出版信息

Am J Chin Med. 2022;50(8):2199-2221. doi: 10.1142/S0192415X22500951. Epub 2022 Oct 20.

DOI:10.1142/S0192415X22500951
PMID:36266751
Abstract

Hyperuricemia (HUA) and its associated metabolic diseases seriously threaten human health, and commensal microbiota has been identified as one of the environmental triggers of HUA. The role of berberine (BBR) in the treatment of HUA has begun to receive attention in recent years. However, how BBR modulates the microbiota to slow HUA progression is unclear. In this study, we showed that BBR alleviated potassium oxonate (PO)-induced HUA in mice by suppressing the expression of xanthine oxidase (XOD) in the liver and urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) in the kidney. The BBR also improved renal inflammation by inhibiting the expression of TNF-[Formula: see text], IL-1[Formula: see text], and caspase-1. Subsequently, we evaluated whether the observed anti-HUA effects of BBR were associated with changes in gut microbial structure in mice. 16S rRNA sequencing data showed that BBR significantly altered the community compositional structure of the gut microbiota. Specifically, BBR enriched the abundance of , , , and . Antibiotic treatment can reverse the anti-HUA effects of BBR that further supports the role of the gut microbiota. In conclusion, our study provides evidence that BBR ameliorates PO-induced HUA by modulating the gut microbiota.

摘要

高尿酸血症(HUA)及其相关的代谢性疾病严重威胁人类健康,共生微生物群已被确定为HUA的环境触发因素之一。近年来,黄连素(BBR)在治疗HUA中的作用开始受到关注。然而,BBR如何调节微生物群以减缓HUA进展尚不清楚。在本研究中,我们发现BBR通过抑制肝脏中的黄嘌呤氧化酶(XOD)以及肾脏中的尿酸转运蛋白1(URAT1)和葡萄糖转运蛋白9(GLUT9)的表达,减轻了氧嗪酸钾(PO)诱导的小鼠高尿酸血症。BBR还通过抑制TNF-α、IL-1β和半胱天冬酶-1的表达改善了肾脏炎症。随后,我们评估了观察到的BBR抗HUA作用是否与小鼠肠道微生物结构的变化有关。16S rRNA测序数据表明,BBR显著改变了肠道微生物群的群落组成结构。具体而言,BBR增加了[具体菌属1]、[具体菌属2]、[具体菌属3]和[具体菌属4]的丰度。抗生素治疗可逆转BBR的抗HUA作用,这进一步支持了肠道微生物群的作用。总之,我们的研究提供了证据,证明BBR通过调节肠道微生物群改善PO诱导的HUA。

相似文献

1
Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota.黄连素通过调节尿酸转运蛋白和肠道微生物群减轻高尿酸血症。
Am J Chin Med. 2022;50(8):2199-2221. doi: 10.1142/S0192415X22500951. Epub 2022 Oct 20.
2
Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.小檗红碱通过调节尿酸转运体和 JAK2/STAT3 信号通路来减轻氧嗪酸钾和次黄嘌呤诱导的高尿酸血症。
Eur J Pharmacol. 2021 Dec 5;912:174592. doi: 10.1016/j.ejphar.2021.174592. Epub 2021 Oct 23.
3
Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.小檗碱对高尿酸血症及肾损伤的作用:基于网络药理学分析和小鼠模型的实验验证。
Drug Des Devel Ther. 2021 Jul 27;15:3241-3254. doi: 10.2147/DDDT.S317776. eCollection 2021.
4
Berberine Regulates the Metabolism of Uric Acid and Modulates Intestinal Flora in Hyperuricemia Rats Model.小檗碱调节高尿酸血症大鼠模型的尿酸代谢和调节肠道菌群。
Comb Chem High Throughput Screen. 2023;26(11):2057-2066. doi: 10.2174/1386207326666221124093228.
5
9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice.9-羟基-8-氧化黄连碱,一种新型的黄连肝脏介导的氧化代谢物,可减轻高尿酸血症小鼠的高尿酸血症和肾脏炎症。
J Ethnopharmacol. 2024 Dec 5;335:118606. doi: 10.1016/j.jep.2024.118606. Epub 2024 Jul 20.
6
Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.东北阿穆尔小檗中黄连碱的降尿酸和肾保护作用:一种针对 Keap1-Nrf2/NLRP3 轴的尿酸调节剂。
J Ethnopharmacol. 2023 Jan 30;301:115775. doi: 10.1016/j.jep.2022.115775. Epub 2022 Oct 2.
7
Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy.通过 AMPK 信号靶向肾脏并调节巨噬细胞极化:小檗碱在尿酸肾病中的治疗机制。
Int Immunopharmacol. 2024 Sep 10;138:112632. doi: 10.1016/j.intimp.2024.112632. Epub 2024 Jul 9.
8
Data mining-guided alleviation of hyperuricemia by Paeonia veitchii Lynch through inhibition of xanthine oxidase and regulation of renal urate transporters.基于数据挖掘的川赤芍对高尿酸血症的缓解作用:通过抑制黄嘌呤氧化酶和调节肾脏尿酸转运体实现
Phytomedicine. 2024 Feb;124:155305. doi: 10.1016/j.phymed.2023.155305. Epub 2023 Dec 19.
9
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.小檗碱通过调节肠道微生物群抑制肠道促炎基因和致癌因子抑制肠道癌变。
BMC Cancer. 2022 May 20;22(1):566. doi: 10.1186/s12885-022-09635-9.
10
Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice.小檗红碱,一种新型的黄连中介的肝微粒体次级代谢产物,可减轻小鼠高尿酸血症肾病。
Phytomedicine. 2023 Jan;108:154521. doi: 10.1016/j.phymed.2022.154521. Epub 2022 Oct 22.

引用本文的文献

1
The anti-hyperuricemia potential of bioactive natural products and extracts derived from traditional Chinese medicines: A review and perspective.中药来源的生物活性天然产物及提取物的抗高尿酸血症潜力:综述与展望
J Pharm Anal. 2025 Jul;15(7):101183. doi: 10.1016/j.jpha.2024.101183. Epub 2025 Jan 3.
2
Absolute Quantitative Metagenomic Analysis Provides More Accurate Insights for the Anti-Colitis Effect of Berberine via Modulation of Gut Microbiota.绝对定量宏基因组分析通过调节肠道微生物群为黄连素的抗结肠炎作用提供更准确的见解。
Biomolecules. 2025 Mar 11;15(3):400. doi: 10.3390/biom15030400.
3
Renal Health Through Medicine-Food Homology: A Comprehensive Review of Botanical Micronutrients and Their Mechanisms.
通过药食同源促进肾脏健康:植物性微量营养素及其作用机制的综合综述
Nutrients. 2024 Oct 18;16(20):3530. doi: 10.3390/nu16203530.
4
Gut microecology: effective targets for natural products to modulate uric acid metabolism.肠道微生态:天然产物调节尿酸代谢的有效靶点
Front Pharmacol. 2024 Aug 28;15:1446776. doi: 10.3389/fphar.2024.1446776. eCollection 2024.
5
Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-C]-glutamine metabolic flux analysis.基于[U-C]-谷氨酰胺代谢通量分析,丹参酮IIA通过调节谷氨酰胺代谢重编程减轻肺纤维化。
J Adv Res. 2025 Apr;70:531-544. doi: 10.1016/j.jare.2024.04.029. Epub 2024 May 1.
6
HCS02-001 Attenuates Hyperuricemia through Gut Microbiota-Dependent Regulation of Uric Acid Biosynthesis and Excretion.HCS02 - 001通过肠道微生物群对尿酸生物合成和排泄的依赖性调节减轻高尿酸血症。
Microorganisms. 2024 Mar 22;12(4):637. doi: 10.3390/microorganisms12040637.
7
Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using C metabolic flux analysis.丹参酮IIA通过碳代谢通量分析改善肺纤维化的能量代谢功能障碍。
J Pharm Anal. 2024 Feb;14(2):244-258. doi: 10.1016/j.jpha.2023.09.008. Epub 2023 Sep 21.
8
Antibiotic-induced gut microbiota dysbiosis has a functional impact on purine metabolism.抗生素诱导的肠道微生物群落失调对嘌呤代谢有功能影响。
BMC Microbiol. 2023 Jul 13;23(1):187. doi: 10.1186/s12866-023-02932-8.
9
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism.小檗碱抗代谢综合征相关肾脏疾病的研究进展:关于作用及机制
Front Pharmacol. 2023 Feb 6;14:1112088. doi: 10.3389/fphar.2023.1112088. eCollection 2023.